The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

BMC Cancer
Sharon A GlynnNorma O'Donovan

Abstract

A number of recent studies have suggested that cancer incidence rates may be lower in patients receiving statin treatment for hypercholesterolemia. We examined the effects of statin drugs on in vitro proliferation, migration and invasion of melanoma cells. The ability of lovastatin, mevastatin and simvastatin to inhibit the melanoma cell proliferation was examined using cytotoxicity and apoptosis assays. Effects on cell migration and invasion were assessed using transwell invasion and migration chambers. Hypothesis testing was performed using 1-way ANOVA, and Student's t-test. Lovastatin, mevastatin and simvastatin inhibited the growth, cell migration and invasion of HT144, M14 and SK-MEL-28 melanoma cells. The concentrations required to inhibit proliferation of melanoma cells (0.8-2.1 microave previously been achieved in a phase I clinical trial of lovastatin in patients with solid tumours, (45 mg/kg/day resulted in peak plasma concentrations of approximately 3.9 micro Our results suggest that statin treatment is unlikely to prevent melanoma development at standard doses. However, higher doses of statins may have a role to play in adjuvant therapy by inhibiting growth and invasion of melanoma cells.

References

Jun 5, 1991·Journal of the National Cancer Institute·A AlbiniW G Stetler-Stevenson
Mar 1, 1991·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·A Martin, M Clynes
Jan 1, 1995·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·G N van MuijenD J Ruiter
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W FeleszkoM Jakóbisiak
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Wojciech FeleszkoMarek Jakóbisiak
Oct 31, 2002·Clinical & Experimental Metastasis·Hernán G FarinaDaniel E Gomez
Feb 28, 2003·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·H SeegerA O Mueck
Jun 6, 2003·Oncogene·Mary J C HendrixRichard E B Seftor
Jul 10, 2003·Menopause : the Journal of the North American Menopause Society·Alfred O MueckDiethelm Wallwiener
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Mohit TrikhaMarian T Nakada
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthijs R GraafHenk-Jan Guchelaar
Nov 9, 2004·Cancer Treatment Reviews·Matthijs R GraafHenk-Jan Guchelaar
Mar 2, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan SleijferJaap Verweij
Apr 23, 2005·Melanoma Research·Yiqun G ShellmanRobert P Dellavalle
May 27, 2005·The New England Journal of Medicine·Jenny N PoynterGad Rennert
Jun 7, 2005·Cancer Detection and Prevention·Sylvie PascoJean-Claude Monboisse
Oct 26, 2005·Archives of Internal Medicine·A Heather EliassenSusan E Hankinson
Nov 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefanos BonovasNikolaos M Sitaras
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Krista M DaleC Michael White
Jan 5, 2006·Journal of the National Cancer Institute·Eric J JacobsEugenia E Calle
Nov 2, 2006·Journal of the National Cancer Institute·Scott R FreemanRobert P Dellavalle
Jan 26, 2007·Clinical and Experimental Pharmacology & Physiology·Andrew J Brown
Mar 21, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Denise M BoudreauJanet R Daling
May 10, 2007·International Journal of Cancer. Journal International Du Cancer·Michael HoffmeisterHermann Brenner

❮ Previous
Next ❯

Citations

Oct 13, 2009·Applied Microbiology and Biotechnology·Javier Barrios-González, Roxana U Miranda
Sep 13, 2011·Apoptosis : an International Journal on Programmed Cell Death·Vladimir N Ivanov, Tom K Hei
Aug 13, 2013·Experimental Cell Research·Fernanda Augusta de Lima Barbosa GuterresSheila Maria Brochado Winnischofer
Oct 28, 2010·The Journal of Clinical Investigation·Sharon A GlynnStefan Ambs
Dec 4, 2008·Future Lipidology·Erhard Bieberich
Feb 19, 2010·Folia Histochemica Et Cytobiologica·Ryszard GalusJarosław Jóźwiak
Sep 16, 2014·Critical Reviews in Oncology/hematology·Peter KubatkaBeata Mladosievicova
Aug 25, 2015·Journal of Microencapsulation·Emilia LicareteManuela Banciu
Sep 26, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tanja Thorskov BladtThomas Ostenfeld Larsen
Feb 14, 2013·Gynecologic Oncology·Elizabeth RobinsonAlan Richardson
May 1, 2012·Cancer Letters·Maja Osmak
May 17, 2011·European Journal of Pharmacology·Alireza GarjaniNasrin Maleki-Dizaji
Jan 26, 2011·Drug Discovery Today·Roy van der MeelAnnette T Byrne
Sep 28, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maria CoimbraRaymond M Schiffelers
Nov 26, 2009·Trends in Cell Biology·Giusi Caldieri, Roberto Buccione
Jan 1, 2010·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Guy FagherazziFrançoise Clavel-Chapelon
Jan 30, 2009·Journal of Cellular and Molecular Medicine·Giusi CaldieriRoberto Buccione
Jul 1, 2009·British Journal of Pharmacology·C Minichsdorfer, M Hohenegger
Oct 23, 2010·International Journal of Dermatology·Farideh Jowkar, Mohammad Reza Namazi
Jun 16, 2009·Medicinal Research Reviews·Marek Jakobisiak, Jakub Golab
Aug 6, 2014·British Journal of Pharmacology·Christine WasingerMartin Hohenegger
Jan 24, 2014·Biochemical Society Transactions·Elizabeth RobinsonAlan Richardson
Dec 25, 2010·Acta Microbiologica Et Immunologica Hungarica·Harleen KaurBhupinder Singh Chadha
Jan 9, 2015·Journal of Pharmaceutical and Biomedical Analysis·Alina PorfireIoan Tomuta
Jul 6, 2010·Biochemical and Biophysical Research Communications·Jennifer Woodard, Leonidas C Platanias
Sep 19, 2015·Journal of Laboratory Automation·Camilo GuzmánDaniel Abankwa
Dec 8, 2017·Nature Communications·Gaetana RestivoLukas Sommer
Feb 12, 2019·Journal of Cellular Physiology·Mehri Bemani NaeiniAmirhossein Sahebkar
Oct 22, 2009·European Journal of Epidemiology·Stefanos BonovasNikolaos M Sitaras
Mar 12, 2009·Melanoma Research·Eliades LedezmaJose E Cardier
Nov 22, 2018·Breast Cancer Research : BCR·Colin H BeckwittAlan Wells

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
ELISA

Clinical Trials Mentioned

NCT00462280

Software Mentioned

GraphPad Prism
Stata Intercooled

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

Related Papers

Melanoma Research
Yiqun G ShellmanRobert P Dellavalle
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
E R KoomenH J Guchelaar
© 2021 Meta ULC. All rights reserved